[Potential therapeutic drugs for novel coronavirus pneumonia]
- PMID: 33137863
- DOI: 10.3760/cma.j.cn112147-20200226-00191
[Potential therapeutic drugs for novel coronavirus pneumonia]
Abstract
The novel coronavirus pneumonia (COVID-19) is still in a serious situation. There is no specific therapeutic drug for COVID-19. At present, drugs, including lopinavir/ritonavir, chloroquine phosphate, abidol, IFN-α atomization and ribavirin, are commonly used in clinical practice. However, further clinical trials are needed to evaluate the efficacy and safety of these drugs. Other potential drugs that may be effective for COVID-19, are worthy of attention, including IL-6 monoclonal antibody, tyrosine protein kinase 1/2 inhibitor, cell therapy drugs, etc. This paper reviews these potential therapeutic drugs for COVID-19.
新型冠状病毒肺炎（COVID-19）目前防控形势依旧严峻，尚无确切有效的特异性治疗药物。临床上应用较多的洛匹那韦/利托那韦、磷酸氯喹、阿比多尔、雾化α-干扰素、利巴韦林等，其有效性和安全性有待进一步确定。除此之外，还有许多潜在治疗药物，包括IL-6单克隆抗体、酪氨酸蛋白激酶1/2抑制剂、细胞治疗药物等，可能对COVID-19有效，值得大家关注。本文将就这些药物进行综述。.
Similar articles
-
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.In Vivo. 2020 Jun;34(3 Suppl):1597-1602. doi: 10.21873/invivo.11949. In Vivo. 2020. PMID: 32503817 Free PMC article. Review.
-
Antiviral therapy for coronavirus disease 2019.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):598-602. doi: 10.11817/j.issn.1672-7347.2020.200211. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32879113 Chinese, English.
-
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5. Trials. 2020. PMID: 33081849 Free PMC article. Clinical Trial.
-
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.J Microbiol Immunol Infect. 2020 Jun;53(3):488-492. doi: 10.1016/j.jmii.2020.03.032. Epub 2020 Apr 3. J Microbiol Immunol Infect. 2020. PMID: 32331982 Free PMC article.
-
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.Virus Res. 2020 Sep;286:198057. doi: 10.1016/j.virusres.2020.198057. Epub 2020 Jun 9. Virus Res. 2020. PMID: 32531236 Free PMC article. Review.
Cited by
-
Analysis of research hotspots in COVID-19 genomics based on citespace software: Bibliometric analysis.Front Cell Infect Microbiol. 2022 Dec 12;12:1060031. doi: 10.3389/fcimb.2022.1060031. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36579345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
